Research ArticleArticle
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
Valentina Varisco, Mauro Viganò, Alberto Batticciotto, Pietro Lampertico, Antonio Marchesoni, Patrizia Gibertini, Raffaele Pellerito, Guido Rovera, Roberto Caporali, Monica Todoerti, Michele Covelli, Antonella Notarnicola, Fabiola Atzeni and Piercarlo Sarzi-Puttini
The Journal of Rheumatology May 2016, 43 (5) 869-874; DOI: https://doi.org/10.3899/jrheum.151105
Valentina Varisco
From the Rheumatology Unit, Ospedale L. Sacco; Hepatology Unit, Ospedale San Giuseppe, University of Milan; A.M. and A. Migliavacca Center for Liver Disease, Division of Gastroenterology and Hepatology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, University of Milan; Rheumatology Day Hospital, Istituto Ortopedico G. Pini, Milan; Rheumatology Unit, Ospedale Mauriziano, Turin; Rheumatology Division, IRCCS Fondazione San Matteo, Università di Pavia, Pavia; University Rheumatology Department, Azienda Ospedaliero Universitaria (AOU) Policlinico, Bari,
Italy.
Mauro Viganò
Alberto Batticciotto
Pietro Lampertico
Antonio Marchesoni
Patrizia Gibertini
Raffaele Pellerito
Guido Rovera
Roberto Caporali
Monica Todoerti
Michele Covelli
Antonella Notarnicola
Fabiola Atzeni
Piercarlo Sarzi-Puttini

REFERENCES
- 1.↵
- Czuczman MS,
- Grillo-López AJ,
- White CA,
- Saleh M,
- Gordon L,
- LoBuglio AF,
- et al.
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- 7.↵
- 8.↵
- 9.↵Rituxan (rituximab) package leaflet. [Internet. Accessed January 18, 2016.] Available from: www.gene.com/download/pdf/rituxan_prescribing.pdf
- 10.↵
- Yeo W,
- Chan TC,
- Leung NW,
- Lam WY,
- Mo FK,
- Chu MT,
- et al.
- 11.↵
- Huang YH,
- Hsiao LT,
- Hong YC,
- Chiou TJ,
- Yu YB,
- Gau JP,
- et al.
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- Artz AS,
- Somerfield MR,
- Feld JJ,
- Giusti AF,
- Kramer BS,
- Sabichi AL,
- et al.
- 16.↵
- Mitroulis I,
- Hatzara C,
- Kandili A,
- Hadziyannis E,
- Vassilopoulos D
- 17.↵
- 18.↵
- 19.↵
- 20.↵
- Smolen JS,
- Landewé R,
- Breedveld FC,
- Dougados M,
- Emery P,
- Gaujoux-Viala C,
- et al.
- 21.↵
- Smolen JS,
- Landewé R,
- Breedveld FC,
- Buch M,
- Burmester G,
- Dougados M,
- et al.
- 22.↵
- 23.↵
- 24.↵
- 25.↵
- 26.↵
- Buti M,
- Morillas R,
- Manzano ML,
- García-Retortillo M,
- Gutiérrez ML,
- Martín L,
- et al.
- 27.↵
- 28.↵
- 29.↵
- Koo YX,
- Tay M,
- Teh YE,
- Teng D,
- Tan DS,
- Tan IB,
- et al.
- 30.↵
In this issue
The Journal of Rheumatology
Vol. 43, Issue 5
1 May 2016
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
Valentina Varisco, Mauro Viganò, Alberto Batticciotto, Pietro Lampertico, Antonio Marchesoni, Patrizia Gibertini, Raffaele Pellerito, Guido Rovera, Roberto Caporali, Monica Todoerti, Michele Covelli, Antonella Notarnicola, Fabiola Atzeni, Piercarlo Sarzi-Puttini
The Journal of Rheumatology May 2016, 43 (5) 869-874; DOI: 10.3899/jrheum.151105
Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc–positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study
Valentina Varisco, Mauro Viganò, Alberto Batticciotto, Pietro Lampertico, Antonio Marchesoni, Patrizia Gibertini, Raffaele Pellerito, Guido Rovera, Roberto Caporali, Monica Todoerti, Michele Covelli, Antonella Notarnicola, Fabiola Atzeni, Piercarlo Sarzi-Puttini
The Journal of Rheumatology May 2016, 43 (5) 869-874; DOI: 10.3899/jrheum.151105